Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glucocorticoid Withdrawal in Early SLE
NCT03804723Unknown
- Sponsor
- University of Pisa
- Start
- Jun 2019
- Primary completion
- Jun 2022
- Modality
- Orthosteric Ligands
01
Overview
Randomised, double-blind trial of prednisone in systemic lupus erythematosus (SLE) (2 arms), sponsored by University of Pisa. Primary endpoint: Proportion of patients with disease flare at 35 months. Status: unknown.
02
Drugs
prednisone
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT03804723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03804723.